Maximum quantity allowed is 999
CAS RN: 333353-44-9 | Product Number: N1090
NBD-556

Purity: >98.0%(HPLC)
- N1-(4-Chlorophenyl)-N2-(2,2,6,6-tetramethyl-4-piperidinyl)ethanediamide
- N1-(4-Chlorophenyl)-N2-(2,2,6,6-tetramethylpiperidin-4-yl)oxalamide
Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
![]() |
---|---|---|---|---|---|
25MG |
NT$6,258
|
8 | 3 | Contact Us | |
100MG |
NT$18,312
|
11 | 2 | Contact Us |
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Supplemental Product Information:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
Product Number | N1090 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__1__7H__2__4ClN__3O__2 = 337.85 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Condition to Avoid | Heat Sensitive |
CAS RN | 333353-44-9 |
Reaxys Registry Number | 10573657 |
PubChem Substance ID | 354334423 |
MDL Number | MFCD00469538 |
Appearance | White to Light yellow to Light orange powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Elemental analysis(Nitrogen) | 11.70 to 13.00 % |
NMR | confirm to structure |
Pictogram |
![]() |
Signal Word | Danger |
Hazard Statements | H301 : Toxic if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
UN Number | UN2811 |
Class | 6.1 |
Packing Group | III |
H.S.code* | 2933.39-000 |
References
- Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4
- Small-Molecule CD4 Mimics Interact with a Highly Conserved Pocket on HIV-1 gp120
- Enhanced exposure of human immunodeficiency virus type 1 primary isolate neutralization epitopes through binding of CD4 mimetic compounds
- K. Yoshimura, S. Harada, J. Shibata, M. Hatada, Y. Yamada, C. Ochiai, H. Tamamura, S. Matsushita, J. Virol. 2010, 84, 7558.
- National Institute of Infectious Diseases AIDS Research Center, Yoshimura Project Laboratory Research Topics “Enhanced Exposure of Human Immunodeficiency Virus Type 1 Primary Isolate Neutralization Epitopes through Binding of CD4 Mimetic Compounds”
- K. Yoshimura, S. Harada, J. Shibata, M. Hatada, Y. Yamada, C. Ochiai, H. Tamamura, S. Matsushita, J. Virol. 2010, 84, 7558.
- Structure-Based Design, Synthesis, and Characterization of Dual Hotspot Small-Molecule HIV-1 Entry Inhibitors
- Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.